PFT
AZN icon

Providence First Trust’s AstraZeneca AZN Stock Holding History

Providence First Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$561K Buy
2,846
+1,000
+54% +$193K 0.2% 112
2025
Q4 		$339K Buy
+1,846
New +$324K 0.12% 141

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Providence First Trust's AZN Position: Q1 2026 in Review

Providence First Trust increased its AstraZeneca (AZN) stake by 54% in Q1 2026, buying an estimated $193K and bringing the position to 2,846 shares worth $561K. The position accounts for 0.2% of the portfolio, ranked #112.

Providence First Trust first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Providence First Trust held 2,846 shares of AstraZeneca worth $561K as of Q1 2026.
  • Providence First Trust bought 1,000 AstraZeneca shares in Q1 2026, an estimated $193K.
  • AstraZeneca made up 0.2% of Providence First Trust's portfolio in Q1 2026, its #112 holding.
  • Providence First Trust first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Providence First Trust's 13F filing for Q1 2026, filed 5 May 2026.